Bye bye, bifocals? New eye drops can fix farsightedness
Posted:
The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of once-daily drops that ease near-object blurriness for up to 10 hours.
Artificial Intelligence is no longer a future concept in healthcare — it is already reshaping how clinicians work, how patients are treated, and how health systems operate under pressure.
But while the excitement around AI continues to grow, the real…
For decades, hospitals were designed around buildings, departments, and paper-based processes.
But healthcare is changing rapidly.
Rising patient demand, workforce shortages, digital transformation, and the shift toward preventative and community-based care are forcing healthcare leaders to rethink what a hospital…
Attendees
Sponsors and Exhibitors
Contact us